Aripiprazole versus ziprasidone for schizophrenia

Hong Ling Yang*, Jiangang ZHENG, Bin Li, Sai Zhao, Wei Zheng

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

Original languageEnglish
Article numberCD012811
JournalCochrane Database of Systematic Reviews
Issue number9
Publication statusPublished - 28 Sep 2017

Scopus Subject Areas

  • Pharmacology (medical)


Dive into the research topics of 'Aripiprazole versus ziprasidone for schizophrenia'. Together they form a unique fingerprint.

Cite this